LXRX
Lexicon Pharmaceuticals, Inc. · Healthcare
Director Raymond Debbane bought $2.5M of Lexicon Pharmaceuticals, Inc.
Bought$2,456,500
$2.50Price
982,600Shares
+21%Stake
What LXRX did for a copier
- $1,000 copied at Tue, Aug 2 open, $2.55
- $1,078
- S&P 500, same days
- −3.5%
Measured over 30 trading days, to the Sep 14 close.
Raymond Debbane's record
3 other buys with 3 months of prices since 2026: on average +38.0% against the S&P 500, and 3 of 3 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Aug 1. Filed Mon, Aug 1, 4:13 PM ET, after the close. Returns use the Aug 2 open and the Sep 14 close. Not investment advice.